QB3 Seminar: David Spellmeyer. "Score! How Your SBIR/STTR Application is Reviewed and Scored"

The SBIR/STTR grant review process can be extremely frustrating and opaque. But if you understand how the reviewers operate, you can improve the chances that your application will succeed. On October 3, David Spellmeyer, an expert SBIR consultant, will reveal the inner workings of an SBIR/STTR Study Section Review Panel. David’s talk will cover panel composition, review assignments, meeting mechanics, critiques, and the scoring process. Join us to learn several ways that you can make your application stand out.

Where & When

Thursday, October 3, 12:00 to 1:00 PM
UCSF Mission Bay, room TBD

Registration link to come.

About the Speaker

david spellmeyer.jpg

David Spellmeyer, Ph.D., is Principal at Interlaken Associates, a consulting firm working with early stage companies on a wide variety of projects, including SBIR/STTR support. David is a regular member of SBIR/STTR Study Sections and recently served as Chair of the IMST-14 Study Section - Small Business: Computational, Modeling, and Biodata Management.

David brings his clients broad technical and business expertise gained in companies both small and large. He has been involved in the development of several technologies as a scientist, including combinatorial chemistry, label free screening, and translational applications of single-cell functional pathway analysis. Development of these technologies required overcoming many difficult steps of standardization, qualification, and validation of components of laboratory and information systems for use in clinical applications.

David works very closely with business development teams and has been involved in establishing over 20 non-dilutive strategic corporate partnerships, 4 mergers and acquisitions, several rounds of venture financing, one joint venture. He is an Adjunct Associate Professor at UCSF and an active mentor at UCSF’s Entrepreneurship Center, California Life Sciences Institute’s FAST Program, and OneStart Americas.